MPTP neurotoxicity and testosterone induce dendritic remodeling of striatal medium spiny neurons in the C57Bl/6 mouse

Parkinson's Disease

Volumn , Issue , 2011, Pages

  Wood, Ruth I ^b   Antzoulatos, Eleni ^a,b   Jakowec, Michael W ^b   Petzinger, Giselle M ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; TESTOSTERONE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CASTRATION; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; CORPUS STRIATUM; DENDRITIC CELL; GOLGI COMPLEX; IMMUNOHISTOCHEMISTRY; LEFT HEMISPHERE; MALE; MOUSE; NERVE CELL; NEUROPROTECTION; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

EID: 80052648551     PISSN: None     EISSN: 20420080     Source Type: Journal    
DOI: 10.4061/2011/138471     Document Type: Article

References (68)

1. Garcia-Segura L. M., Chowen J. A., Parducz A., Naftolin F., Gonadal hormones as promoters of structural synaptic plasticity: cellular mechanisms Progress in Neurobiology 1994 44 3 279 307 (Pubitemid 24344297)
2. Garcia-Segura L. M., Azcoitia I., DonCarlos L. L., Neuroprotection by estradiol Progress in Neurobiology 2001 63 1 29 60
3. Biaek M., Zaremba P., Borowicz K. K., Czuczwar S. J., Neuroprotective role of testosterone in the nervous system Polish Journal of Pharmacology 2004 56 5 509 518 (Pubitemid 40123650)
4. Shulman L. M., Bhat V., Gender disparities in Parkinson's disease Expert Review of Neurotherapeutics 2006 6 3 407 416
5. Fahn S., Description of Parkinson's disease as a clinical syndrome Annals of the New York Academy of Sciences 2003 991 1 14 (Pubitemid 36793796)
6. Becker J. B., Oestrogen effects on dopaminergic function in striatum Novartis Foundation Symposium 2000 230 134 151
7. Dluzen D. E., Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system Journal of Neurocytology 2000 29 5-6 387 399 (Pubitemid 32154521)
8. Schober A., Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP Cell and Tissue Research 2004 318 1 215 224 (Pubitemid 39366054)
9. Dluzen D. E., McDermott J. L., Liu B., Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/B1 mice Neurotoxicology and Teratology 1996 18 5 603 606 (Pubitemid 26346106)
10. Disshon K. A., Dluzen D. E., Estrogen as a neuromodulator of MPTP-induced neurotoxicity: effects upon striatal dopamine release Brain Research 1997 764 1-2 9 16 (Pubitemid 27380635)
11. Dluzen D., Estrogen decreases corpus striatal neurotoxicity in response to 6- hydroxydopamine Brain Research 1997 767 2 340 344 (Pubitemid 27435781)
12. Miller D. B., Ali S. F., O'Callaghan J. P., Laws S. C., The impact of gender and estrogen on striatal dopaminergic neurotoxicity Annals of the New York Academy of Sciences 1998 844 153 165 (Pubitemid 28367804)
13. Murray H. E., Pillai A. V., Mcarthur S. R., Razvi N., Datla K. P., Dexter D. T., Gillies G. E., Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females Neuroscience 2003 116 1 213 222 (Pubitemid 36110447)
14. Shughrue P. J., Estrogen attenuates the MPTP-induced loss of dopamine neurons from the mouse SNc despite a lack of estrogen receptors (ER and ER ) Experimental Neurology 2004 190 2 468 477 (Pubitemid 39505000)
15. Ferraz A. C., Matheussi F., Szawka R. E., Rizelio V., Delattre A. M., Rigon P., Hermel E.. D. E. S., Xavier L. L., Achaval M., Anselmo-Franci J. A., Evaluation of estrogen neuroprotective effect on nigrostriatal dopaminergic neurons following 6-hydroxydopamine injection into the substantia nigra pars compacta or the medial forebrain bundle Neurochemical Research 2008 33 7 1238 1246
16. Becker J. B., Gender differences in dopaminergic function in striatum and nucleus accumbens Pharmacology Biochemistry and Behavior 1999 64 4 803 812
17. Bourque M., Dluzen D. E., Di Paolo T., Neuroprotective actions of sex steroids in Parkinson's disease Frontiers in Neuroendocrinology 2009 30 2 142 157
18. Dluzen D. E., Effects of testosterone upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system of C57/B1 mice Brain Research 1996 715 1-2 113 118 (Pubitemid 26141656)
19. Ekue A., Boulanger J. F., Morissette M., Di Paolo T., Lack of effect of testosterone and dihydrotestosterone compared to 17 -oestradiol in 1-methyl-4-phenyl-1,2,3,6,tetrahydropyridine-mice Journal of Neuroendocrinology 2002 14 9 731 736
20. Dluzen D., Jain R., Liu B., Modulatory effects of testosterone on 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced neurotoxicity Journal of Neurochemistry 1994 62 1 94 101
21. Gillies G. E., Murray H. E., Dexter D., McArthur S., Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease Pharmacology Biochemistry and Behavior 2004 78 3 513 522 (Pubitemid 38906665)
22. Jackson-Lewis V., Jakowec M., Burke R. E., Przedborski S., Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Neurodegeneration 1995 4 3 257 269
23. Jakowec M. W., Nixon K., Hogg E., McNeill T., Petzinger G. M., Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway Journal of Neuroscience Research 2004 76 4 539 550 (Pubitemid 38580469)
24. Paxinos G., Franklin K., The Mouse Brain in Stereotaxic Coordinates 2001 New York, NY, USA Academic Press
25. Fisher B. E., Petzinger G. M., Nixon K., Hogg E., Bremmer S., Meshul C. K., Jakowec M. W., Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse basal ganglia Journal of Neuroscience Research 2004 77 3 378 390 (Pubitemid 38970982)
26. Petzinger G. M., Walsh J. P., Akopian G., Hogg E., Abernathy A., Arevalo P., Turnquist P., Vukovi M., Fisher B. E., Togasaki D. M., Jakowec M. W., Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury Journal of Neuroscience 2007 27 20 5291 5300 (Pubitemid 46790176)
27. Gomez D. M., Newman S. W., Medial nucleus of the amygdala in the adult syrian hamster: a quantitative golgi analysis of gonadal hormonal regulation of neuronal morphology Anatomical Record 1991 231 4 498 509
28. Gibb R., Kolb B., A method for vibratome sectioning of Golgi-Cox stained whole rat brain Journal of Neuroscience Methods 1998 79 1 1 4 (Pubitemid 28248234)
29. Kurosaki R., Muramatsu Y., Watanabe H., Michimata M., Matsubara M., Imai Y., Araki T., Role of dopamine transporter against MPTP (1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine) neurotoxicity in mice Metabolic Brain Disease 2003 18 2 139 146 (Pubitemid 36718126)
30. Monaghan M. M., Leddy L., Sung M. -L. A., Albinson K., Kubek K., Pangalos M. N., Reinhart P. H., Zaleska M. M., Comery T. A., Social odor recognition: a novel behavioral model for cognitive dysfunction in Parkinson's disease Neurodegenerative Diseases 2010 7 13 153 159
31. Petroske E., Meredith G. E., Callen S., Totterdell S., Lau Y. S., Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment Neuroscience 2001 106 3 589 601 (Pubitemid 32925247)
32. Vukovi M. G., Wood R. I., Holschneider D. P., Abernathy A., Togasaki D. M., Smith A., Petzinger G. M., Jakowec M. W., Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury Neurobiology of Disease 2008 32 2 319 327
33. McArthur S., Murray H. E., Dhankot A., Dexter D. T., Gillies G. E., Striatal susceptibility to a dopaminergic neurotoxin is independent of sex hormone effects on cell survival and DAT expression but is exacerbated by central aromatase inhibition Journal of Neurochemistry 2007 100 3 678 692 (Pubitemid 46095618)
34. Day M., Wang Z., Ding J., An X., Ingham C. A., Shering A. F., Wokosin D., Ilijic E., Sun Z., Sampson A. R., Mugnaini E., Deutcch A. Y., Sesack S. R., Arbuthnott G. W., Surmeier D. J., Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models Nature Neuroscience 2006 9 2 251 259 (Pubitemid 43164549)
35. Pulipparacharuvil S., Renthal W., Hale C. F., Taniguchi M., Xiao G., Kumar A., Russo S. J., Sikder D., Dewey C. M., Davis M. M., Greengard P., Nairn A. C., Nestler E. J., Cowan C. W., Cocaine regulates MEF2 to control synaptic and behavioral plasticity Neuron 2008 59 4 621 633
36. Vickers C. A., Stephens B., Bowen J., Arbuthnott G. W., Grant S. G. N., Ingham C. A., Neurone specific regulation of dendritic spines in vivo by post synaptic density 95 protein (PSD-95) Brain Research 2006 1090 1 89 98 (Pubitemid 43817941)
37. Lyons K. E., Hubble J. P., Trster A. I., Pahwa R., Koller W. C., Gender differences in Parkinson's disease Clinical Neuropharmacology 1998 21 2 118 121 (Pubitemid 28152962)
38. Haaxma C. A., Bloem B. R., Borm G. F., Oyen W. J. G., Leenders K. L., Eshuis S., Booij J., Dluzen D. E., Horstink M. W. I. M., Gender differences in Parkinson's disease Journal of Neurology, Neurosurgery and Psychiatry 2007 78 8 819 824 (Pubitemid 47204585)
39. Antzoulatos E., Jakowec M. W., Petzinger G. M., Wood R. I., Sex differences in motor behavior in the MPTP mouse model of Parkinson's disease Pharmacology Biochemistry and Behavior 2010 95 4 466 472
40. Neely M. D., Schmidt D. E., Deutch A. Y., Cortical regulation of dopamine depletion-induced dendritic spine loss in striatal medium spiny neurons Neuroscience 2007 149 2 457 464 (Pubitemid 47576538)
41. Smith A. D., Bolam J. P., The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones Trends in Neurosciences 1990 13 7 259 265 (Pubitemid 20193455)
42. Krasnova I. N., Cadet J. L., Methamphetamine toxicity and messengers of death Brain Research Reviews 2009 60 2 379 407
43. Li Y., Kolb B., Robinson T. E., The location of persistent amphetamine-induced changes in the density of dendritic spines on medium spiny neurons in the nucleus accumbens and caudate-putamen Neuropsychopharmacology 2003 28 6 1082 1085
44. Jedynak J. P., Uslaner J. M., Esteban J. A., Robinson T. E., Methamphetamine-induced structural plasticity in the dorsal striatum European Journal of Neuroscience 2007 25 3 847 853
45. Robinson T. E., Kolb B., Structural plasticity associated with exposure to drugs of abuse Neuropharmacology 2004 47 1 33 46 (Pubitemid 39298251)
46. Baik J. H., Picetti R., Saiardi A., Thiriet G., Dierich A., Depaulis A., Le Meur M., Borrelli E., Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors Nature 1995 377 6548 424 428
47. Xu M., Guo Y., Vorhees C. V., Zhang J., Behavioral responses to cocaine and amphetamine administration in mice lacking the dopamine D1 receptor Brain Research 2000 852 1 198 207 (Pubitemid 30017751)
48. Drago J., Gerfen C. R., Lachowicz J. E., Steiner H., Hollon T. R., Love P. E., Ooi G. T., Grinberg A., Lee E. J., Sing Ping Huang., Bartlett P. F., Jose P. A., Sibley D. R., Westphal H., Altered striatal function in a mutant mouse lacking D(1A) dopamine receptors Proceedings of the National Academy of Sciences of the United States of America 1994 91 26 12564 12568
49. Camp D. M., Becker J. B., Robinson T. E., Sex differences in the effects of gonadectomy on amphetamine-induced rotational behavior in rats Behavioral and Neural Biology 1986 46 3 491 495 (Pubitemid 17222851)
50. Gao X., Dluzen D. E., The effect of testosterone upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system Brain Research 2001 892 1 63 69 (Pubitemid 32126567)
51. Dluzen D. E., Anderson L. I., Pilati C. F., Methamphetamine-gonadal steroid hormonal interactions: effects upon acute toxicity and striatal dopamine concentrations Neurotoxicology and Teratology 2002 24 2 267 273 (Pubitemid 34274008)
52. Myers R. E., Anderson L. I., Dluzen D. E., Estrogen, but not testosterone, attenuates methamphetamine-evoked dopamine output from superfused striatal tissue of female and male mice Neuropharmacology 2003 44 5 624 632 (Pubitemid 36369142)
53. Lewis C., Dluzen D. E., Testosterone enhances dopamine depletion by methamphetamine in male, but not female, mice Neuroscience Letters 2008 448 1 130 133
54. Leranth C., Petnehazy O., MacLusky N. J., Gonadal hormones affect spine synaptic density in the CA1 hippocampal subfield of male rats Journal of Neuroscience 2003 23 5 1588 1592 (Pubitemid 36314713)
55. Cherry J. A., Tobet S. A., DeVoogd T. J., Baum M. J., Effects of sex and androgen treatment on dendritic dimensions of neurons in the sexually dimorphic preoptic/anterior hypothalamic area of male and female ferrets Journal of Comparative Neurology 1992 323 4 577 585
56. Shughrue P. J., Estrogen attenuates the MPTP-induced loss of dopamine neurons from the mouse SNc despite a lack of estrogen receptors (ER and ER ) Experimental Neurology 2004 190 2 468 477 (Pubitemid 39505000)
57. Mitra S. W., Hoskin E., Yudkovitz J., Pear L., Wilkinson H. A., Hayashi S., Pfaff D. W., Ogawa S., Rohrer S. P., Schaeffer J. M., McEwen B. S., Alves S. E., Immunolocalization of estrogen receptor in the mouse brain: comparison with estrogen receptor Endocrinology 2003 144 5 2055 2067 (Pubitemid 36543346)
58. Kritzer M. F., Selective colocalization of immunoreactivity for intracellular gonadal hormone receptors and tyrosine hydroxylase in the ventral tegmental area, substantia nigra, and retrorubral fields in the rat Journal of Comparative Neurology 1997 379 2 247 260 (Pubitemid 27113617)
59. Roy E. J., Buyer D. R., Licari V. A., Estradiol in the striatum: effects on behavior and dopamine receptors but no evidence for membrane steroid receptors Brain Research Bulletin 1990 25 2 221 227 (Pubitemid 20277308)
60. Ramirez A. D., Liu X., Menniti F. S., Repeated estradiol treatment prevents MPTP-induced dopamine depletion in male mice Neuroendocrinology 2003 77 4 223 231 (Pubitemid 36667656)
61. Dluzen D. E., McDermott J. L., Liu B., Estrogen alters MPTP-induced neurotoxicity in female mice: effects on striatal dopamine concentrations and release Journal of Neurochemistry 1996 66 2 658 666 (Pubitemid 26036698)
62. Ookubo M., Yokoyama H., Takagi S., Kato H., Araki T., Effects of estrogens on striatal damage after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in male and female mice Molecular and Cellular Endocrinology 2008 296 1-2 87 93
63. Kppers E., Beyer C., Expression of aromatase in the embryonic and postnatal mouse striatum Molecular Brain Research 1998 63 1 184 188 (Pubitemid 28559100)
64. Roselli C. E., Resko J. A., Sex differences in androgen-regulated expression of cytochrome P450 aromatase in the rat brain Journal of Steroid Biochemistry and Molecular Biology 1997 61 36 365 374 (Pubitemid 27459891)
65. Wagner C. K., Morrell J. I., Distribution and steroid hormone regulation of aromatase mRNA expression in the forebrain of adult male and female rats: a cellular-level analysis using in situ hybridization Journal of Comparative Neurology 1996 370 1 71 84 (Pubitemid 26192346)
66. Wagner C. K., Morrell J. I., Neuroanatomical distribution of aromatase mRNA in the rat brain: indications of regional regulation Journal of Steroid Biochemistry and Molecular Biology 1997 61 36 307 314 (Pubitemid 27455694)
67. Ragonese P., D'Amelio M., Salemi G., Aridon P., Gammino M., Epifanio A., Morgante L., Savettieri G., Risk of Parkinson disease in women: effect of reproductive characteristics Neurology 2004 62 11 2010 2014 (Pubitemid 38738213)
68. Popat R. A., Van Den Eeden S. K., Tanner C. M., McGuire V., Bernstein A. L., Bloch D. A., Leimpeter A., Nelson L. M., Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease Neurology 2005 65 3 383 390 (Pubitemid 41099800)